NeuroVision

NeuroVision is a comprehensive neuroscience company focused on providing scientifically validated diagnostic tests and biomarkers for the early detection and monitoring of amyloid pathology associated with Alzheimer's disease. The company has developed a novel retinal imaging technology currently being used in multiple clinical trials globally. By accessing unique datasets, we offer data aggregation services, analysis, biostatistics, and machine learning algorithm applications for large image repositories and other biomarker data to enhance collective understanding and predictive capabilities for neurodegenerative diseases.